|
OMIM |
Link |
Information gain |
01 |
|
immune defect due to absence of thymus
|
[NCBI]
|
0.00804344
|
|
|
IGAD1
|
[NCBI]
|
0.00514087
|
|
|
immunoglobulin m, level of
|
[NCBI]
|
0.0029801
|
|
|
malignant atrophic papulosis
|
[NCBI]
|
0.00219174
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
0.00146373
|
|
|
neutropenia, chronic familial
|
[NCBI]
|
0.00134594
|
|
|
myeloma, multiple
|
[NCBI]
|
0.000293414
|
|
|
anemia, autoimmune hemolytic
|
[NCBI]
|
0.000224922
|
|
|
tuftsin deficiency
|
[NCBI]
|
0.000192793
|
|
|
SLE
|
[NCBI]
|
0.000171513
|
|
|
lymphoblastic transformation, intrinsic defect in
|
[NCBI]
|
0.000143912
|
|
|
granulocytopenia with immunoglobulin abnormality
|
[NCBI]
|
0.000143912
|
|
|
globulin anomaly involving beta (2a)-globulin
|
[NCBI]
|
0.000143912
|
|
|
asthma, short stature, and elevated iga
|
[NCBI]
|
0.000143912
|
|
|
cyanosis and hepatic disease
|
[NCBI]
|
0.000143912
|
|
|
pulmonary fibrosis, idiopathic
|
[NCBI]
|
0.000140595
|
|
|
IGHG1
|
[NCBI]
|
0.000140108
|
|
|
CVID
|
[NCBI]
|
0.000113694
|
|
|
renal tubular acidosis iii
|
[NCBI]
|
0.000112362
|
|
|
RA
|
[NCBI]
|
0.000107415
|
|
|
hypoproteinemia, hypercatabolic
|
[NCBI]
|
0.000100479
|
|
|
cirrhosis, familial
|
[NCBI]
|
0.000100479
|
|
|
CF
|
[NCBI]
|
9.31554e-05
|
|
|
CGD
|
[NCBI]
|
8.44592e-05
|
|
|
IGKC
|
[NCBI]
|
8.29427e-05
|
|
|
complement factor i deficiency
|
[NCBI]
|
7.26973e-05
|
|
|
SCAR1
|
[NCBI]
|
7.26973e-05
|
|
|
WAS
|
[NCBI]
|
6.92661e-05
|
|
|
BTK
|
[NCBI]
|
6.82182e-05
|
|
|
THC1
|
[NCBI]
|
6.79595e-05
|
|
|
EAOH
|
[NCBI]
|
6.07643e-05
|
|
|
kartagener syndrome
|
[NCBI]
|
5.42164e-05
|
|
|
DMPK
|
[NCBI]
|
4.66985e-05
|
|
|
HBFQTL1
|
[NCBI]
|
4.5937e-05
|
|
|
SCIDX1
|
[NCBI]
|
4.5937e-05
|
|
|
CLL
|
[NCBI]
|
4.51921e-05
|
|
|
HIGM1
|
[NCBI]
|
4.06273e-05
|
|
|
AT
|
[NCBI]
|
3.78208e-05
|
|
|
ALB
|
[NCBI]
|
3.55689e-05
|
|
|
IGHA2
|
[NCBI]
|
3.11762e-05
|
|
|
FCGRT
|
[NCBI]
|
2.88439e-05
|
|
|
TNFRSF13C
|
[NCBI]
|
2.82488e-05
|
|
|
IGHE
|
[NCBI]
|
2.7227e-05
|
|
|
AMY1A
|
[NCBI]
|
2.46875e-05
|
|
|
TNFRSF13B
|
[NCBI]
|
2.44066e-05
|
|
|
PGM3
|
[NCBI]
|
2.44066e-05
|
|
|
CP
|
[NCBI]
|
2.39754e-05
|
|
|
CEACAM6
|
[NCBI]
|
2.38857e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
2.23664e-05
|
|
|
AICDA
|
[NCBI]
|
2.22e-05
|
|
|
CYBB
|
[NCBI]
|
2.15232e-05
|
|
|
HP
|
[NCBI]
|
2.11729e-05
|
|
|
ALPS
|
[NCBI]
|
2.0364e-05
|
|
|
complement component 2 deficiency
|
[NCBI]
|
2.02584e-05
|
|
|
TNFRSF6
|
[NCBI]
|
1.98963e-05
|
|
|
RHCE
|
[NCBI]
|
1.94492e-05
|
|
|
C3
|
[NCBI]
|
1.83862e-05
|
|
|
B2M
|
[NCBI]
|
1.69437e-05
|
|
|
HLA-A
|
[NCBI]
|
1.62035e-05
|
|
|
LIPC
|
[NCBI]
|
1.56072e-05
|
|
|
MJD
|
[NCBI]
|
1.50645e-05
|
|
|
CHS
|
[NCBI]
|
1.43096e-05
|
|
|
von willebrand disease
|
[NCBI]
|
1.41091e-05
|
|
|
UCN
|
[NCBI]
|
1.39217e-05
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
1.31238e-05
|
|
|
AIS
|
[NCBI]
|
1.2182e-05
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
1.19786e-05
|
|
|
MBL2
|
[NCBI]
|
9.25646e-06
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
6.99246e-06
|
|
|
PF4
|
[NCBI]
|
6.81767e-06
|
|
|
TTR
|
[NCBI]
|
5.21003e-06
|
|
|
EPO
|
[NCBI]
|
4.26193e-06
|
|
|
ALD
|
[NCBI]
|
4.12289e-06
|
|
|
CRH
|
[NCBI]
|
4.05555e-06
|
|
|
DHFR
|
[NCBI]
|
2.86046e-06
|
|
|
NPY
|
[NCBI]
|
2.09508e-06
|
|
|
VEGF
|
[NCBI]
|
1.96031e-06
|
|
|
LPL
|
[NCBI]
|
1.23647e-06
|
|
|
MBP
|
[NCBI]
|
9.89395e-07
|
|
|
AFP
|
[NCBI]
|
7.64551e-07
|
|
|
TNF
|
[NCBI]
|
6.76843e-07
|
|
|
MPO
|
[NCBI]
|
5.90497e-07
|
|
|
PRL
|
[NCBI]
|
2.08967e-07
|
|
|
MG
|
[NCBI]
|
9.78364e-08
|
|
|
CEACAM5
|
[NCBI]
|
4.67178e-08
|
|